公开(公告)号：US20230110394A1

公开(公告)日：2023-04-13

申请号：US17934280

申请日：2022-09-22

申请人： Johnson & Johnson Vision Care, Inc.

发明人： William Gooch ,  Scott F. Ansell ,  Gerard Sheehan ,  Timothy Burkill

IPC分类号： A45C11/00

摘要： There is described a contact lens package containing a bowl for holding a contact lens and a flange around the bowl which may be made from a different polymer material than the bowl. The packages comprise at least one interface tab with at least one slot so that the second polymer material forming the flange can encapsulate the tab providing a mechanical interlock displaying good flexural strength.

公开(公告)号：US20220340760A1

公开(公告)日：2022-10-27

申请号：US17810049

申请日：2022-06-30

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Derek Nankivil ,  Shivkumar Mahadevan ,  Dawn D. Wright

IPC分类号： C09B62/465 ,  G02B1/04 ,  C08L83/04 ,  C08L77/00 ,  A61L27/00 ,  G02C7/04 ,  G02C7/10 ,  C08F230/08

摘要： Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices.

公开(公告)号：US20220340759A1

公开(公告)日：2022-10-27

申请号：US17809619

申请日：2022-06-29

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Donald E. Riederer ,  Patricia Martin ,  Shivkumar Mahadevan ,  Dawn D. Wright ,  John R. Buch ,  Jessica Cannon

IPC分类号： C09B62/465 ,  G02B1/04 ,  C08L83/04 ,  C08L77/00 ,  A61L27/00 ,  G02C7/04 ,  G02C7/10 ,  C08F230/08

摘要： Described are polymerizable high energy light absorbing compounds. The compounds absorb various wavelengths of ultraviolet and/or high energy visible light and are suitable for incorporation in various products, such as biomedical devices and ophthalmic devices. Such devices exhibit a number of desirable properties, including favorable rates of pervaporation.

公开(公告)号：US11449982B2

公开(公告)日：2022-09-20

申请号：US16792355

申请日：2020-02-17

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Michael F. Widman ,  Peter W. Sites ,  Jasmin Laferriere ,  D. Scott Dewald ,  Bradley W. Walker

IPC分类号： G01B11/06 ,  G06K9/00 ,  G06T7/00

摘要： A method of measuring the thickness of an ophthalmic lens includes forming an ophthalmic lens over a convexly curved surface of a forming optic, the ophthalmic lens including a light absorptive component, and with the ophthalmic lens remaining over the convexly curved surface of the forming optic, measuring the thickness of the ophthalmic lens using information about the light absorptive component of the ophthalmic lens and an intensity reference value associated with the forming optic. The method includes passing light having a wavelength through the ophthalmic lens and the forming optic, whereupon the light absorptive component of the ophthalmic lens absorbs some of the light passing through the ophthalmic lens. The light passing through the ophthalmic lens and the forming optic, which is not absorbed by the light absorptive component of the ophthalmic lens, is used to generate an image having pixel intensity data.

公开(公告)号：US20220229313A1

公开(公告)日：2022-07-21

申请号：US17716957

申请日：2022-04-08

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Benjamin Straker

IPC分类号： G02C7/04 ,  G02C7/02

摘要： Ophthalmic lenses are described herein. An example ophthalmic lens may comprise a first surface. The example ophthalmic lens may comprise a second surface disposed opposite the first surface and defining a volume of lens material therebetween. A thickness profile of the volume of lens material may be derived from one or more eyelid profiles such that a thickness gradient of the volume of lens material is oriented to be substantially orthogonal to a target eyelid margin shape.

公开(公告)号：US20220206187A1

公开(公告)日：2022-06-30

申请号：US17410139

申请日：2021-08-24

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Kevin P. McCabe ,  Robert B. Steffen ,  Hélène Aguilar ,  W. Anthony Martin ,  Susan W. Neadle ,  Ann-Marie Wong Meyers ,  Douglas G. Vanderlaan ,  Dominic P. Gourd ,  Kristy L. Canavan ,  Gregory A. Hill

IPC分类号： G02B1/04 ,  G02C7/04 ,  A61L12/04 ,  A61L12/08 ,  A61L27/34 ,  A61L27/50 ,  A61L27/54 ,  B29D11/00 ,  G02C13/00

摘要： This invention relates to comfortable ophthalmic devices and methods of producing such devices.

公开(公告)号：US11360325B2

公开(公告)日：2022-06-14

申请号：US16272019

申请日：2019-02-11

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Minghan Chen ,  C. Benjamin Wooley

IPC分类号： G02C7/02 ,  G02C7/04

摘要： An ophthalmic lens may comprise a main body comprising an optic zone and a peripheral zone disposed adjacent the optic zone, wherein the optic zone comprises a refractive structure that exhibits a first optical power and a diffractive structure disposed within the optic zone, wherein the diffractive structure exhibits a second optical power, wherein the ophthalmic lens is associated with a first target SKU optical power.

公开(公告)号：US11311510B2

公开(公告)日：2022-04-26

申请号：US16789793

申请日：2020-02-13

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Annabelle Gallois-Bernos

IPC分类号： A61K31/232 ,  A61K31/557 ,  A61K31/215 ,  A61K31/5575 ,  A61K31/661 ,  A61K9/00 ,  A61K31/16 ,  A61K31/201 ,  A61K31/202 ,  A61K31/203 ,  A61K31/683 ,  A61K9/08

摘要： The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a polyol wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. Anti-inflammatory lipid mediators can be selected from the group consisting of polyunsaturated fatty acids (e.g., omega-three and omega-six fatty acids), resolvins or a metabolically stable analog, protectins or a metabolically stable analog, lipoxins or a metabolically stable analog, prostaglandins or a metabolically stable analog, retinoic acids, endocannabinoids, metabolites thereof, and mixtures thereof. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens.

公开(公告)号：US20220088894A1

公开(公告)日：2022-03-24

申请号：US17024883

申请日：2020-09-18

申请人： Johnson & Johnson Vision Care, Inc.

发明人： Michael F. Widman ,  John B. Enns ,  P. Mark Powell ,  Peter W. Sites

IPC分类号： B29D11/00

摘要： This invention discloses apparatus for generating an ophthalmic lens with at least a portion of one surface free-formed from a Reactive Mixture. In some embodiments, an ophthalmic lens is formed on a substrate with an arcuate optical quality surface via a source of actinic radiation controllable to cure a definable portion of a volume of Reactive Mixture.

公开(公告)号：US11213198B2

公开(公告)日：2022-01-04

申请号：US16444352

申请日：2019-06-18

申请人： Johnson & Johnson Vision Care, Inc.

发明人： John E. Greivenkamp, Jr. ,  Gregory A. Williby

IPC分类号： A61B3/02 ,  A61B3/00 ,  A61B3/032

摘要： A computer, a high resolution monitor and a patient interface is utilized to implement a visual contrast sensitivity function measurement test. More specifically, a computerized video system is configured to implement a tilted-grating forced choice contrast sensitivity function test. The invention utilizes known measurement methods for the visual contrast sensitivity function and automates their use by computerizing the system and couples it with a patient-interactive user interface in order to produce an accurate quantitative result.